Does SECUKINUMAB Cause Product substitution issue? 15 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Product substitution issue have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.0% of all adverse event reports for SECUKINUMAB.
15
Reports of Product substitution issue with SECUKINUMAB
0.0%
of all SECUKINUMAB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Product substitution issue From SECUKINUMAB?
Of the 15 reports, 2 (13.3%) required hospitalization, and 1 (6.7%) were considered life-threatening.
Is Product substitution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Product substitution issue?
AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (2,832)
BUPROPION (1,578)
METHYLPHENIDATE (1,408)
CLONAZEPAM (1,288)
LAMOTRIGINE (979)
ALBUTEROL (864)
LEVOTHYROXINE (803)
DULOXETINE (766)
ESTRADIOL (692)
SERTRALINE (636)
Which SECUKINUMAB Alternatives Have Lower Product substitution issue Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG